Physician profile
Ellores E Brailey
NPI 1225134588
$1,021.46
in general payments reported to CMS, 2019-2025
18 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2021: $12.28 · 2022: $37.76 · 2023: $16.22 · 2024: $233 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $159.60 | 2024 | Evenity, Prolia |
| Abbvie INC. | $140.45 | 2019-2025 | |
| Lupin INC. | $125.00 | 2019 | |
| Novo Nordisk INC | $108.87 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $82.34 | 2024-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $58.63 | 2025 | Trelegy Ellipta |
| Vanda Pharmaceuticals INC. | $54.75 | 2019 | |
| Pfizer INC. | $45.06 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $42.98 | 2024-2025 | Gvoke Hypopen |
| Sunovion Pharmaceuticals INC. | $35.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $31.89 | 2025 | Nexium |
| Bayer Healthcare Pharmaceuticals INC. | $27.03 | 2019-2025 | |
| Lundbeck LLC | $23.90 | 2025 | Rexulti |
| Paratek Pharmaceuticals, INC. | $23.87 | 2022 | |
| Merck Sharp & Dohme LLC | $16.22 | 2023 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15.70 | 2025 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $15.47 | 2025 | The Cologuard Plus Collection Kit |
| Vbi Vaccine (Delaware) INC. | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellores Brailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.